Christopher Wilfong is the Chief Business Officer at Neogene Therapeutics. In addition, Mr. Wilfong is an Operating Partner at Two River Consulting, LLC, where he is a co-founder and has held interim management positions in several Two River portfolio companies, including Kite Pharma, Inc., Kronos Bio, Inc., Arno Therapeutics, Inc., and Nile Therapeutics, Inc.
Prior to joining Two River, Mr. Wilfong was a Director at Trustbridge Partners, a China-based growth equity firm, where he led the US investment team and negotiated multiple US-China joint ventures and strategic partnerships in the healthcare and media industries. Prior to that, Mr. Wilfong was a Consultant at Bain & Company.
Mr. Wilfong earned his B.S. in Economics magna cum laude from the Wharton School of Business at the University of Pennsylvania, and received his M.B.A. from the Massachusetts Institute of Technology Sloan School of Management.